333 related articles for article (PubMed ID: 16266355)
1. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.
Raskin J; Pritchett YL; Wang F; D'Souza DN; Waninger AL; Iyengar S; Wernicke JF
Pain Med; 2005; 6(5):346-56. PubMed ID: 16266355
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine for the management of diabetic peripheral neuropathic pain: response profile.
Pritchett YL; McCarberg BH; Watkin JG; Robinson MJ
Pain Med; 2007; 8(5):397-409. PubMed ID: 17661853
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine for patients with diabetic peripheral neuropathic pain: a 6-month open-label safety study.
Raskin J; Wang F; Pritchett YL; Goldstein DJ
Pain Med; 2006; 7(5):373-85. PubMed ID: 17014595
[TBL] [Abstract][Full Text] [Related]
5. Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomes.
Armstrong DG; Chappell AS; Le TK; Kajdasz DK; Backonja M; D'Souza DN; Russell JM
Pain Med; 2007; 8(5):410-8. PubMed ID: 17661854
[TBL] [Abstract][Full Text] [Related]
6. Duloxetine vs. placebo in patients with painful diabetic neuropathy.
Goldstein DJ; Lu Y; Detke MJ; Lee TC; Iyengar S
Pain; 2005 Jul; 116(1-2):109-18. PubMed ID: 15927394
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies.
Kajdasz DK; Iyengar S; Desaiah D; Backonja MM; Farrar JT; Fishbain DA; Jensen TS; Rowbotham MC; Sang CN; Ziegler D; McQuay HJ
Clin Ther; 2007; 29 Suppl():2536-46. PubMed ID: 18164920
[TBL] [Abstract][Full Text] [Related]
8. Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain.
Raskin J; Smith TR; Wong K; Pritchett YL; D'Souza DN; Iyengar S; Wernicke JF
J Palliat Med; 2006 Feb; 9(1):29-40. PubMed ID: 16430342
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of duloxetine in the treatment of diabetic peripheral neuropathic pain in older patients.
Wasan AD; Ossanna MJ; Raskin J; Wernicke JF; Robinson MJ; Hall JA; Edwards SE; Lipsius S; Meyers AL; McCarberg BH
Curr Drug Saf; 2009 Jan; 4(1):22-9. PubMed ID: 19149522
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.
Mallinckrodt CH; Prakash A; Andorn AC; Watkin JG; Wohlreich MM
J Psychiatr Res; 2006 Jun; 40(4):337-48. PubMed ID: 16271726
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of duloxetine in patients with chronic low back pain.
Skljarevski V; Desaiah D; Liu-Seifert H; Zhang Q; Chappell AS; Detke MJ; Iyengar S; Atkinson JH; Backonja M
Spine (Phila Pa 1976); 2010 Jun; 35(13):E578-85. PubMed ID: 20461028
[TBL] [Abstract][Full Text] [Related]
12. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L
Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897
[TBL] [Abstract][Full Text] [Related]
13. An open-label 52-week clinical extension comparing duloxetine with routine care in patients with diabetic peripheral neuropathic pain.
Wernicke JF; Wang F; Pritchett YL; Smith TR; Raskin J; D'Souza DN; Iyengar S; Chappell AS
Pain Med; 2007 Sep; 8(6):503-13. PubMed ID: 17716324
[TBL] [Abstract][Full Text] [Related]
14. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF
J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.
Arnold LM; Rosen A; Pritchett YL; D'Souza DN; Goldstein DJ; Iyengar S; Wernicke JF
Pain; 2005 Dec; 119(1-3):5-15. PubMed ID: 16298061
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.
Skljarevski V; Ossanna M; Liu-Seifert H; Zhang Q; Chappell A; Iyengar S; Detke M; Backonja M
Eur J Neurol; 2009 Sep; 16(9):1041-8. PubMed ID: 19469829
[TBL] [Abstract][Full Text] [Related]
18. Does treatment with duloxetine for neuropathic pain impact glycemic control?
Hardy T; Sachson R; Shen S; Armbruster M; Boulton AJ
Diabetes Care; 2007 Jan; 30(1):21-6. PubMed ID: 17192327
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of duloxetine treatment of diabetic peripheral neuropathic pain between patients with and without cardiovascular conditions.
Wernicke JF; Prakash A; Kajdasz DK; Houston J
J Diabetes Complications; 2009; 23(5):349-59. PubMed ID: 18768332
[TBL] [Abstract][Full Text] [Related]
20. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.
Lunn MP; Hughes RA; Wiffen PJ
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD007115. PubMed ID: 24385423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
